CLEGF(CLEGF)
CLEGF
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $47.59B | $49.39B | $51.43B | $52.36B |
| Low | $47.18B | $48.97B | $50.99B | $51.91B |
| High | $48.22B | $50.04B | $52.11B | $53.05B |
| EBITDA Avg | $3.56B | $3.70B | $3.85B | $3.92B |
| Low | $3.53B | $3.67B | $3.82B | $3.89B |
| High | $3.61B | $3.75B | $3.90B | $3.97B |
| EBIT Avg | $1.81B | $1.87B | $1.95B | $1.99B |
| Low | $1.79B | $1.86B | $1.94B | $1.97B |
| High | $1.83B | $1.90B | $1.98B | $2.01B |
| Net Income Avg | $1.36B | $1.46B | $1.51B | — |
| Low | $1.35B | $1.44B | $1.50B | — |
| High | $1.38B | $1.48B | $1.54B | — |
| EPS Avg | $1.02 | $1.09 | $1.13 | — |
| Low | $1.01 | $1.08 | $1.12 | — |
| High | $1.04 | $1.11 | $1.15 | — |
| Analysts (Rev / EPS) | 12 / 1 | 5 / 1 | 10 / 1 | 6 / — |